Fernández González Leticia Gabriela, Reyes Veiga Ana Laura, Oliver Patricia, Gretter Mariella Terán
Cátedra de Radioquímica, Departamento Estrella Campos, Facultad de Química, Universidad de la República- Uruguay, Montevideo. Uruguay.
Centro Uruguayo de Imagenología Molecular (CUDIM), Montevideo. Uruguay.
Curr Radiopharm. 2017 Aug 24;10(2):131-138. doi: 10.2174/1874471010666170703125709.
The aim of this work was to assess the influence of treatment with U-Caspofungin, on the quality of diagnostic scintigraphic images of induced lesions in nude mice undergoing both bacterial and fungal infections and to determine the level of specificity of 99mTc-tricarbonyl-Caspofungin to discriminate between fungal or bacterial infections. In vitro studies on the behaviour of the 99mTc-tricarbonyl-Caspofungin complex binding percentage at different yeast concentrations of Candida albicans or Staphyolococcus aureus were determined. The incubation was performed with and without U-Caspofungin. In vivo evaluation was performed of 6 groups of athymic mice: sham, inflammation (LPS), fungal infection with Candida albicans (CA) and bacterial infection with Staphylocuccus aureus (SA). In vitro studies showed that the uptake of the complex by both yeasts and bacteria, depends on the concentration of colony forming units (cfu), and that this uptake is favoured by the presence of UCaspofungin that increases the membrane permeability to the 99mTc-tricarbonyl-Caspofungin complex. In vivo evaluation showed low uptake in sterile inflammation model and moderate to high uptake in infections models both treated or not with U-Caspofungin. The results of biodistributions were compatible with scintigraphic images.
The uptake of the complex depends on the load of microorganisms, but it presents high sensibility, even at low concentrations of the infecting agent. The treatment with U-Caspofungin has no influence on the quality of the scintigraphic images used for diagnosis and localization of infection foci.
本研究的目的是评估用优立康唑治疗对同时患有细菌和真菌感染的裸鼠诱导性病变诊断闪烁图像质量的影响,并确定99mTc-三羰基-伏立康唑区分真菌或细菌感染的特异性水平。对不同酵母浓度的白色念珠菌或金黄色葡萄球菌进行了99mTc-三羰基-伏立康唑复合物结合百分比行为的体外研究。在有和没有优立康唑的情况下进行孵育。对6组无胸腺小鼠进行了体内评估:假手术组、炎症组(脂多糖)、白色念珠菌真菌感染组(CA)和金黄色葡萄球菌细菌感染组(SA)。体外研究表明,酵母和细菌对复合物的摄取取决于菌落形成单位(cfu)的浓度,并且优立康唑的存在有利于这种摄取,优立康唑可增加膜对99mTc-三羰基-伏立康唑复合物的通透性。体内评估显示,在无菌炎症模型中摄取较低,在感染模型中,无论是否用优立康唑治疗,摄取均为中度至高度。生物分布结果与闪烁图像一致。
复合物的摄取取决于微生物负荷,但即使在感染剂浓度较低时也具有高敏感性。优立康唑治疗对用于感染灶诊断和定位的闪烁图像质量没有影响。